Addressing these limitations and further investigating the role of NINJ1 in early‐stage AAA development and therapeutic interventions may enhance our understanding of AAA pathogenesis and facilitate the identification of novel strategies for the treatment of this challenging disease. This evidence concerns the gene NINJ1 and triple-A syndrome.